Dr Reddy’s gets 11 observations from USFDA for Hyderabad plant Industry-The Economic Times — April 28, 2017 comments off The audit of our formulations manufacturing plant-3 at Bachupally, Hyderabad by the USFDA has been completed today, said Dr Reddy’s Lab.
The audit of our formulations manufacturing plant-3 at Bachupally, Hyderabad by the USFDA has been completed today, said Dr Reddy’s Lab.